The RYR3 (Ryanodine Receptor 3) gene encodes a calcium release channel protein that plays a critical role in intracellular calcium signaling. As one of three ryanodine receptor isoforms, RYR3 is expressed throughout the brain and is implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy.
| Property |
Value |
| Gene Symbol |
RYR3 |
| Full Name |
Ryanodine Receptor 3 |
| Chromosomal Location |
15q13.3 |
| NCBI Gene ID |
6263 |
| OMIM |
180903 |
| Ensembl ID |
ENSG00000198853 |
| UniProt ID |
Q15413 |
| Protein Length |
4,870 amino acids |
| Inheritance |
Autosomal Dominant |
RYR3 is a large intracellular calcium release channel primarily located on the endoplasmic reticulum (ER) membrane. Like other ryanodine receptor isoforms (RYR1 and RYR2), RYR3 forms a massive tetrameric channel complex that regulates calcium release from ER stores.
- N-terminal cytoplasmic domain: Multiple SPRY domains and FKBP binding sites
- Transmembrane domain: Six transmembrane helices forming the channel pore
- C-terminal channel domain: Forms the Ca²⁺ conduction pathway
RYR3 participates in several critical neuronal functions:
- Synaptic plasticity: Calcium release through RYR3 modulates long-term potentiation (LTP) and long-term depression (LTD)
- Neuronal excitability: RYR3-mediated calcium signals regulate membrane potential and firing patterns
- Gene expression: Calcium-dependent transcription through calcineurin and CaMK pathways
- Mitochondrial calcium uptake: RYR3-generated calcium signals can be taken up by mitochondria
Unlike RYR1 (primarily skeletal muscle) and RYR2 (primarily cardiac muscle), RYR3 has distinct properties:
- Lower expression levels: RYR3 is expressed at lower levels than RYR1/2 in most tissues
- Wider tissue distribution: RYR3 is found in brain, smooth muscle, and various tissues
- Calcium leak function: RYR3 may function more as a calcium leak channel than a triggering channel
- Modulatory role: RYR3 often modulates calcium signals rather than initiating them
RYR3 is significantly implicated in Alzheimer's disease pathogenesis:
Alterations in RYR3 contribute to the calcium dysregulation hypothesis of AD:
- Elevated basal calcium: RYR3 dysfunction may lead to elevated resting calcium levels in neurons
- Impaired calcium homeostasis: Altered RYR3 function disrupts normal calcium buffering
- Synaptic calcium overload: Excessive calcium entry through RYR3 contributes to synaptic dysfunction
Aβ oligomers can directly interact with RYR channels, leading to:
- Potentiated pathological calcium release
- Accelerated synaptic toxicity
- Neuronal death through excitotoxic mechanisms
- Calcium dysregulation through RYR3 may accelerate tau phosphorylation
- Hyperphosphorylated tau further disrupts calcium homeostasis
- Creates a vicious cycle of neurodegeneration
RYR3 alterations are also implicated in PD:
- Dopaminergic neuron vulnerability: RYR3-mediated calcium dysregulation may contribute to selective vulnerability of substantia nigra neurons
- Mitochondrial dysfunction: RYR3 alterations compound mitochondrial defects in PD
- Alpha-synuclein interaction: Calcium dysregulation may accelerate alpha-synuclein aggregation
RYR3 is associated with epilepsy:
- Seizure susceptibility: Altered RYR3 function may lower seizure thresholds
- Temporal lobe epilepsy: RYR3 expression changes in hippocampal neurons
- Excitotoxicity: Dysregulated calcium release contributes to excitotoxic cell death
- RYR3 has been linked to bipolar disorder through genetic studies
- Calcium signaling abnormalities are a hallmark of the disorder
RYR3 is widely expressed in the central nervous system:
- Hippocampus — CA1-CA3 regions, dentate gyrus (critical for learning and memory)
- Cerebral cortex — Layers II-IV, particularly in pyramidal neurons
- Cerebellum — Purkinje cells and granule cells
- Thalamus — Relay nuclei
- Basal ganglia — Striatum, substantia nigra
- Neurons: RYR3 expressed in excitatory glutamatergic and inhibitory GABAergic neurons
- Astrocytes: Lower expression in glial cells
- Microglia: Limited expression under normal conditions
Dysregulated RYR3 function leads to calcium overload through several mechanisms:
- Channel hyperactivity: Mutations or alterations can cause excessive channel opening
- Leaky channels: Structural changes increase basal calcium leak
- Impaired regulation: Loss of normal regulatory mechanisms
Excess calcium activates multiple harmful pathways:
- Calpain activation: Calcium-dependent protease degrades synaptic proteins
- Mitochondrial permeability transition: Pores open, releasing pro-apoptotic factors
- ROS generation: Calcium-induced oxidative stress
- DNA damage: Activates repair pathways and apoptosis
- RYR modulators: Compounds targeting RYR channel function
- Calcium stabilizers: Agents that normalize calcium homeostasis
- Anti-excitotoxic compounds: Drugs preventing calcium overload
- Channel blockers: Developing selective RYR3 inhibitors
- Gene therapy: Approaches to normalize RYR3 expression
- Combination therapies: Targeting RYR3 with disease-modifying agents
- Lanner JT, et al. (2010). Ryanodine receptors: structure and function. J Bioenerg Biomembr
- Berridge MJ (2010). Calcium signalling and Alzheimer's disease. Neurochem Res
- LaFerla FM (2002). Calcium dyshomeostasis and calcium signalling in Alzheimer's disease. Nat Rev Neurosci
- Stutzmann GE (2007). Calcium dysregulation in Alzheimer's disease. Neuroscientist
- Werner AI, et al. (2012). RYR3 variants in bipolar disorder. Mol Psychiatry
- Zucchi R, et al. (2010). Ryanodine receptor blockers for neurodegenerative diseases. Expert Opin Ther Pat